Junshi Biotech announced that on August 31, 2026, the company completed the cancellation of 6.3 million H shares purchased between May 26, 2026 and June 4, 2026, accounting for 1.89% of the total number of shares issued before repurchase. The repurchase price per share was HK$17.51. After the cancellation was completed, the total number of shares issued by the company was 327,888,000, including 57,352,000 H shares, 270,536,000 A shares, and 0 treasury shares.

Junshi Biotech announced that on August 31, 2026, the company completed the cancellation of 6.3 million H shares purchased between May 26, 2026 and June 4, 2026, accounting for 1.89% of the total number of shares issued before repurchase. The repurchase price per share was HK$17.51. After the cancellation was completed, the total number of shares issued by the company was 327,888,000, including 57,352,000 H shares, 270,536,000 A shares, and 0 treasury shares.